More:    MJNA HOME        CANNABIS NEWS        SHOP        CONTACT 

  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
Medical Marijuana, Inc. Subsidiary HempMeds® Announces Sponsorship of Last-Ever Run 4 Hope Festival & 5K

Medical Marijuana, Inc. Subsidiary HempMeds® Announces Sponsorship of Last-Ever Run 4 Hope Festival & 5K

by adminAdrianRamirez | Sep 14, 2018 | HempMeds, Press Releases

SAN DIEGO, Sept. 14, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, today announced that subsidiary HempMeds® is sponsoring the seventh and last-ever annual Run 4 Hope Festival and 5K in Coppell,...
Medical Marijuana, Inc. Subsidiary HempMeds® Announces Participation at Natural Products Expo East

Medical Marijuana, Inc. Subsidiary HempMeds® Announces Participation at Natural Products Expo East

by adminAdrianRamirez | Sep 11, 2018 | HempMeds, Press Releases

SAN DIEGO, Sept.11, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, subsidiary HempMeds® announced today that it will be attending and exhibiting at Natural Products Expo East in Baltimore,...
Forbes, Entrepreneur, Green Rush Daily, and More Provide Coverage of the Latest MJNA News

Forbes, Entrepreneur, Green Rush Daily, and More Provide Coverage of the Latest MJNA News

by adminAdrianRamirez | Aug 22, 2018 | HempMeds, Kannalife Sciences, Real Scientific Hemp Oil

Investing in the cannabis industry, cannabis marketing techniques, and cannabis patents lead Medical Marijuana, Inc.’s headlines this past week. Medical Marijuana, Inc.’s role in the cannabis industry continues to attract the attention of national and international...
Medical Marijuana, Inc. Announces Q2 2018 as the Largest Sales Revenue Quarter in Company History

Medical Marijuana, Inc. Announces Q2 2018 as the Largest Sales Revenue Quarter in Company History

by adminAdrianRamirez | Aug 21, 2018 | HempMeds, Kannaway, Press Releases

SAN DIEGO, Aug. 21, 2018 — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that the company and its subsidiaries Kannaway®, HempMeds®, HempMeds® Mexico and HempMeds® Brasil have booked...
Medical Marijuana, Inc. Garners International News Coverage in Westword Newspaper, Trade Outlets for Selling World’s Only Hops-Derived CBD Product

Medical Marijuana, Inc. Garners International News Coverage in Westword Newspaper, Trade Outlets for Selling World’s Only Hops-Derived CBD Product

by adminAdrianRamirez | Aug 9, 2018 | HempMeds, Kannaway, Press Releases

SAN DIEGO, Aug. 9, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, today announced that it has garnered global news coverage in Westword newspaper and other outlets for its partnership with Peak Health...
Medical Marijuana, Inc. and Subsidiaries 2018 Revenue Surpasses Its Total 2017 Revenue

Medical Marijuana, Inc. and Subsidiaries 2018 Revenue Surpasses Its Total 2017 Revenue

by adminAdrianRamirez | Jul 31, 2018 | Dixie Botanicals, HempMeds, Kannaway, Press Releases

SAN DIEGO, July 31, 2018 — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that its portfolio of companies 2018 revenue has surpassed its total 2017 revenue. “Our company is growing...
« Older Entries
Next Entries »

Recent Posts

  • Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
  • Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets
  • Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson’s Disease Treatment

Recent Comments

No comments to show.

Home     Company    Education     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.